Kenvue Inc. is the world's largest pure-play consumer health company by revenue, with $15.4 billion in net sales in 2023. The company operates through three reportable segments: Self Care, Skin Health and Beauty, and Essential Health. Kenvue's portfolio includes iconic brands such as Tylenol®, Neutrogena®, Listerine®, Johnson's®, BAND-AID®, Aveeno®, Zyrtec®, and Nicorette®. The company has a global presence in more than 165 countries.

• Employees: 22,000 (as of December 31, 2023)
• Geographic Footprint: More than 165 countries
• Headquarters: Skillman, New Jersey
• Founded: 2022
• Revenue: $15.4 billion (FY2023)
• Key Subsidiaries/Brands: Tylenol®, Neutrogena®, Listerine®, Johnson's®, BAND-AID®, Aveeno®, Zyrtec®, and Nicorette®

• CEO: Thibaut Mongon
• CFO: Paul Ruh
• Chief Accounting Officer: Heather Howlett
• Board Chair: Larry J. Merlo

• Annual Revenue: $15.4 billion (FY2023)
• Net Income: $1.664 billion (FY2023)
• Total Assets: $27.851 billion (as of December 31, 2023)
• Employees: 22,000 (as of December 31, 2023)
• Key Financial Highlights: Net sales increased by 3.3% compared to the prior year.

Kenvue operates in three main product categories:

• Self Care: Includes pain care, cough, cold, and allergy products, as well as other self-care solutions like digestive health and smoking cessation.
• Skin Health and Beauty: Offers face and body care, and hair, sun, and other products.
• Essential Health: Provides oral care, baby care, and other essential health products, such as women's health and wound care.

Kenvue operates through three reportable business segments:

• Self Care: 41.8% of net sales
• Skin Health and Beauty: 28.3% of net sales
• Essential Health: 29.9% of net sales

Kenvue's strategy focuses on delivering science-backed innovative products and solutions centered around consumer health. The company aims to leverage its global scale and flexible distribution network to drive growth. Key initiatives include a digital-first approach to marketing and product development, as well as a commitment to building a resilient and sustainable business.

Kenvue operates in the consumer health and personal care sectors, which are large and dynamic. The company competes with a broad set of competitors, including consumer healthcare businesses, global CPG companies, regional companies, generic OTC manufacturers, and niche-oriented brands. Key competitors include Haleon, Procter & Gamble, Reckitt Benckiser Group, Beiersdorf, L'Oréal, and Unilever.

• Market Risks: Intense competition, changing consumer preferences, and the potential for damage to brand reputation.
• Operational Risks: Reliance on third-party manufacturers and suppliers, potential disruptions to supply chains, and cybersecurity incidents.
• Financial Risks: Exposure to foreign currency fluctuations, inflation, and changes in interest rates.
• Regulatory Risks: Compliance with a broad range of laws and regulations, including those related to product safety, labeling, and marketing.